<!DOCTYPE html>
<html>

	<head>
	 <meta charset="UTF-8">
	 <meta name="description" content="This is an awesome website!">
	<title>Bill's BioPharma Watch</title>
<link href="stylesheet.css" rel="stylesheet">
	</head>
	<body style="background-color:tan" >
		<div class="header-title">
			<div><h1 class="header-title">Bill's BioPharma Watch</h1></div>
				<map name="bino-img">
					<area shape="circle" coords=600,100,100 ><img class="bino-img" src="bino1.png" /><img></div>
					</map>
				</div>
		</div>
<ul>
	<li><a class="nav-item" href="index.html" >Home</a></li>
	<li><a class="nav-item" href="About.html" >About</a></li>
	<li><a class="nav-item" href="WatchList.html">WatchList</a></li>
	<li><div class="dropdown">
			<button class="dropbtn"style="background-color:tan;">2020</button>
				<div class="dropdown-content">
				<!--<a href="September.html" >September</a> !-->
				<a href="October.html" >October</a>
				<a href="November.html" >November</a>
				<a href="December.html" >December</a>

			</div>
		</div>
	<li><div class="dropdown">
	<button class="dropbtn"style="background-color:tan;">2021</button>
		<div class="dropdown-content">
			<a href="Janurary.html" >Janurary</a>
			<a href="February.html" >February</a>
			<a href="March.html" >March</a></li>
			</div>
		</div>
</ul>

<!-- TradingView Widget BEGIN -->
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com" rel="noopener" target="_blank"><span class="blue-text">Quotes</span></a> by TradingView</div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-tickers.js" async>
  {
  "symbols": [
    {
      "description": "",
      "proName": "NASDAQ:LQDA"
    },
    {
      "description": "",
      "proName": "NASDAQ:ADMP"
    },
    {
      "description": "",
      "proName": "NASDAQ:SUPN"
    }
  ],
  "colorTheme": "light",
  "isTransparent": false,
  "locale": "en"
}
  </script>
</div>
<!-- TradingView Widget END -->

<p align="center">
		<img width="500" src="November.png" />

		<hr>
		<center>
		<table border="2px">
			<thead>
				<tr>
					<th>Ticker</th>
					<th>PDUFA Date</th>
					<th>Price Target</th>
				</tr>
			</thead>
			<tr>
				<td><a href="#SUPN">SUPN</a></td>
				<td>November 8th</td>
				<td>24 - 31$</td>
			</tr>
			<tr>
				<td><a href="#ADMP">ADMP</a></td>
				<td>November 15th</td>
				<td>1.50$</td>
			</tr>
			<tr>
				<td><a href="#LQDA">LQDA</a></td>
				<td>November 24th</td>
				<td>None</td>
			</tr>
		</table>
		</center>
		<hr>

		<center>
		<h2 align="center" id="SUPN">Supernus Pharmaceuticals Inc</h2>
	</center>
		<Center>
		<!-- TradingView Widget BEGIN -->
		<div class="tradingview-widget-container">
		  <div class="tradingview-widget-container__widget"></div>
		  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/ADMP/" rel="noopener" target="_blank"></a></div>
		  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
		  {
		  "symbol": "SUPN",
		  "width": 1000,
		  "locale": "en",
		  "colorTheme": "light",
		  "isTransparent": false
		}
		  </script>
		</div>
		</center>

		<p><b>S</b>upernus Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in neurology and psychiatry
			in the United States. The company offers Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and in children 6 to 17 years of age; and
			Trokendi XR, an extended release topiramate, which is used for the prophylaxis of migraine headache, as well as for the treatment of epilepsy. Its product candidates comprise SPN-812, a viloxazine hydrochloride,
			 which has completed phase III clinical trial that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-809, a viloxazine hydrochloride, which is in phase II ready clinical trial
			 for the treatment of depression; SPN-604 extended release oxcarbazepine, which is in phase III clinical trial for the treatment of bipolar disorder; and SPN-817 that is in phase I clinical trial to treat
			 severe pediatric epilepsy disorders. The company markets its products through pharmaceutical wholesalers and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to
			  conduct a phase II clinical program for NV-5138 in treatment-resistant depression. Supernus Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Rockville, Maryland. <i>Source Fidelity.com</i>
		</p>
		<p>
		<center>
			<div class="pdufa-container">
		    <div class="pdufa-container"><b><u>ADMP PDUFA Dates</u></b></div>
		    <div class="pdufa-container">SPN-812 (P301) - <b>November 8th</b></div>
				</div>


		  <span class="research-container"><h3>Links</h3>
			  <span><a class="research-container" href="https://www.supernus.com/" target="_blank" >Company Website</a></span>
			  <span><a class="research-container" href="https://finance.yahoo.com/quote/ADMP?p=SUPN" target="_blank">Yahoo Fiance</a></span>
			  <span><a class="research-container" href="https://stocktwits.com/symbol/SUPN" target="_blank">StockTwits</a></span>
			  <span><a class="research-container" href="https://www.tradingview.com/symbols/NASDAQ-SUPN/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></span>
			  <span><a class="research-container" href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></span>
			</center>
		</span>
		<p><hr></p>
<h2 align="center" id="ADMP">ADAMIS PHARMACEUTICALS CORP</h2>
<Center>
<!-- TradingView Widget BEGIN -->
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/ADMP/" rel="noopener" target="_blank"></a></div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
  {
  "symbol": "ADMP",
  "width": 1000,
  "locale": "en",
  "colorTheme": "light",
  "isTransparent": false
}
  </script>
</div>
</center>
<!-- TradingView Widget END -->

<p><b>A</b>damis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States.
   The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including
   anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma;
   Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides
   corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and
   certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California. <i>Source Fidelity.com</i>
</p>
<p>
<center>
	<div class="pdufa-container">
    <div class="pdufa-container"><b><u>ADMP PDUFA Dates</u></b></div>
    <div class="pdufa-container">ZIMHI (naloxone HCI Injection) - <b>November 15th</b></div>
		</div>


  <span class="research-container"><h3>Links</h3>
	  <span><a class="research-container" href="http://www.adamispharmaceuticals.com/" target="_blank" >Company Website</a></span>
	  <span><a class="research-container" href="https://finance.yahoo.com/quote/ADMP?p=ADMP" target="_blank">Yahoo Fiance</a></span>
	  <span><a class="research-container" href="https://stocktwits.com/symbol/ADMP" target="_blank">StockTwits</a></span>
	  <span><a class="research-container" href="https://www.tradingview.com/symbols/NASDAQ-ADMP/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></span>
	  <span><a class="research-container" href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></span>
	</center>
</span>
<p><hr></p>

<h2 align="center" id="LQDA">LIQUIDIA TECHNOLOGIES INC</h2>

<center>
<div class="tradingview-widget-container">
  <div class="tradingview-widget-container__widget"></div>
  <div class="tradingview-widget-copyright"><a href="https://www.tradingview.com/symbols/ADMP/" rel="noopener" target="_blank"></a></div>
  <script type="text/javascript" src="https://s3.tradingview.com/external-embedding/embed-widget-symbol-info.js" async>
  {
  "symbol": "ADMP",
  "width": 1000,
  "locale": "en",
  "colorTheme": "light",
  "isTransparent": false
}
  </script>
</div>
</center>

<p><b>L</b>iquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of novel products which utilize PRINT technology to
	transform the lives of patients. Its lead product candidate is LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials for the treatment of pulmonary
	arterial hypertension. The company also develops LIQ865, which completed Phase 1 clinical trials for the treatment of local post-operative pain. It has collaboration agreement with the
	University of North Carolina. Liquidia Technologies, Inc. was founded in 2004 and is headquartered in Morrisville, North Carolina. <i>Source Fidelity.com</i>
</p>


<center>
  <div class="pdufa-container">
    <div class="pdufa-container"><b><u>LQDA PDUFA Dates</u></b></div>
    <div class="pdufa-container">LIQ861 (INSPIRE) - <b>November 24th</b></div>
	</div>



  <span class="research-container"><h3>Links</h3>
	  <span><a class="research-container" href="https://liquidia.com/" target="_blank" >Company Website</a></span>
	  <span><a class="research-container" href="https://finance.yahoo.com/quote/LQDA?p=LQDA" target="_blank">Yahoo Fiance</a></span>
	  <span><a class="research-container" href="https://stocktwits.com/symbol/LQDA" target="_blank">StockTwits</a></span>
	  <span><a class="research-container" href="https://www.tradingview.com/symbols/NASDAQ-LQDA/?utm_campaign=mini-symbol-overview&utm_medium=widget_new" target="_blank">TradingView</a></span>
	  <span><a class="research-container" href="https://www.biopharmcatalyst.com/" target="_blank">BioPharmCatalyst.com</a></span>
	</span>
</center>


<hr>
<hr>





	</body>
</html>
